Systemic Sclerosis - Diffuse Cutaneous

Immunology·MeSH: Scleroderma, Diffuse

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Systemic Sclerosis - Diffuse Cutaneous?

There are 1 clinical trial targeting Systemic Sclerosis - Diffuse Cutaneous tracked by BioSniper.

What is the prevalence of Systemic Sclerosis - Diffuse Cutaneous?

The estimated prevalence of Systemic Sclerosis - Diffuse Cutaneous is approximately 5.0 per 100,000 population.

Deep-dive into Systemic Sclerosis - Diffuse Cutaneous

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Systemic Sclerosis - Diffuse Cutaneous — Drugs in Development & Clinical Trials | BioSniper